Delivery Order SPE2DB20D1100-SPE2DB24FA7V6
Award Date 3/18/24
Potential Completion Date 3/19/24
Potential Value $3K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, valued at $2,936.44, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distributor. The contract is for the delivery of INSULIN ASPART 100 UNIT/ML PEN 3ML, with a period of performance through March 13, 2024. The contract is a firm-fixed price delivery order, with no set-aside designation. AmerisourceBergen Drug Corp is the prime contractor, with no major...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,766.50 firm fixed-price delivery order is for the supply of INSULIN ASPART 100 UNIT/ML PEN 3ML. This order is not set aside and is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical. The IDC enables Amerisourcebergen to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,610.83 firm fixed-price delivery order is for the supply of INSULIN ASPART 100 UNIT/ML PEN 3ML medical products. The contract has an ultimate completion date of December 26, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,474.68 firm fixed-price delivery order is for the supply of INSULIN ASPART 100 UNIT/ML PEN 3ML, a critical medical commodity used in the treatment of diabetes. The contract has an ultimate completion date of May 1, 2024 and was awarded on April 30, 2024. This delivery order is part of a larger $999,999,999...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order valued at $1,106.01 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Insulin Aspart 100 Unit/ML Pen 3ML. This delivery order is part of a larger indefinite delivery contract (IDC) between DLA and AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for...
- The U.S. Defense Logistics Agency (DLA) has awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract to provide Insulin Aspart 100 Unit/mL Pen 3mL. The contract has a potential value of $28,673.28 and a completion date of January 31, 2024. This delivery order is issued under a single award indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that runs through December 31, 2025. The IDC serves as the...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $10,206.40 firm-fixed-price contract is for the delivery of INSULIN ASPART 100 UNIT/ML PEN 3ML, a specialty pharmaceutical product. The order has a completion date of November 22, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,212.02 firm-fixed-price delivery order is for the supply of Insulin Aspart 100 Unit/mL Pen 3mL, with a performance period ending on April 10, 2024. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which provides a broad...
- This federal contract award, with a ceiling value of $26,133.17, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of INSULIN ASPART 100 UNIT/ML PEN 3ML medical supplies, with a performance period ending on January 17, 2024. This contract is a Delivery Order, with a Firm Fixed Price pricing type, and is not designated with any set-aside requirements, indicating...
- This federal contract award, with ID SPE2DB20D1047|SPE2DB24FF30G, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,312.13 fixed-price delivery order is for the supply of Insulin Aspart 100 Unit/mL Pen 3mL, with a completion date of November 30, 2023. The contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...